Board
INOVIQ has a high-calibre Board with the healthcare leadership, strategic, financial markets and commercial experience to guide the business towards its vision of becoming a leading precision diagnostics company.
David Williams
Chairman & Non-Executive Director
Experienced biotechnology director and investment banker extensive strategic, corporate and financial markets experience.
Currently Chairman of PolyNovo Ltd (ASX:PNV), Chairman of RMA Global Ltd (ASX:RMY), and is Managing Director of corporate advisory firm Kidder Williams Ltd.
Previously Chairman and major shareholder of Medical Developments International Ltd. Major shareholder of Healthily Pty Ltd.
Dr Geoff Cumming
Non-Executive Director
Healthcare and biotechnology director with extensive diagnostics industry experience.
Previously Managing Director Roche Diagnostic Systems (Oceania), MD/CEO Biosceptre International Ltd, and MD/CEO of Anteo Diagnostics Ltd.
Currently NED AnteoTech Ltd.
Max Johnston
Non-Executive Director
Healthcare industry director and international business leader with extensive experience across medtech, pharmaceuticals, consumer healthcare and consumer goods.
Currently NED Neurotech International.
Previously President and CEO of Johnson & Johnson Pacific, Chairman of AusCann Ltd, NED of PolyNovo Ltd, Medical Developments International Ltd, Tissue Repair Ltd and CannPal Animal Therapeutics Ltd.
Philip Powell
Non-Executive Director
Healthcare industry director and chartered accountant with extensive investment banking experience specialising in capital raisings, IPOs, mergers and acquisitions and other transactions across pharma, food and agriculture.
Previously at OAMPS Ltd and Arthur Andersen, and NED at RMA Global Ltd, Polynovo Ltd and Medical Developments International Ltd.
Mary Harney
Non-Executive Director
Experienced Non-Executive Director and Chief Executive, bringing a deep understanding of applied life science research, in addition to experience in biopharmaceutical regulatory affairs, and commercialisation.
Currently Chair of Oncology One Pty Ltd. Previously Chair of Race Oncology (ASX: RAC) and Microbio Limited.
